Kaneka Corporation
Kaneka Corporation (KANKF) Financial Performance & Income Statement Overview
Explore the financials of Kaneka Corporation (KANKF), including yearly and quarterly data on income, cash flow, and balance sheets.
Kaneka Corporation (KANKF) Income Statement & Financial Overview
View the income breakdown for Kaneka Corporation KANKF across both annual and quarterly reports.
| Metric | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $204.15B | $207.09B | $197.58B | $198.38B |
| Cost of Revenue | $146.64B | $150.06B | $142.92B | $142.95B |
| Gross Profit | $57.51B | $57.02B | $54.66B | $55.44B |
| Gross Profit Ratio | $0.28 | $0.28 | $0.28 | $0.28 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $47.61B | $46.99B | $45.84B | $45.16B |
| Operating Expenses | $47.61B | $46.99B | $45.83B | $45.16B |
| Total Costs & Expenses | $194.25B | $197.05B | $188.76B | $188.11B |
| Interest Income | $295.00M | $0.00 | $0.00 | $0.00 |
| Interest Expense | $1.02B | $0.00 | $1.05B | $1.02B |
| Depreciation & Amortization | $10.85B | $10.19B | $10.71B | $10.19B |
| EBITDA | $14.52B | $20.23B | $19.53B | $20.47B |
| EBITDA Ratio | $0.07 | $0.10 | $0.10 | $0.10 |
| Operating Income | $9.90B | $10.03B | $8.82B | $10.28B |
| Operating Income Ratio | $0.05 | $0.05 | $0.04 | $0.05 |
| Other Income/Expenses (Net) | -$950.00M | $2.15B | -$3.33B | -$131.00M |
| Income Before Tax | $8.95B | $12.18B | $5.49B | $10.14B |
| Income Before Tax Ratio | $0.04 | $0.06 | $0.03 | $0.05 |
| Income Tax Expense | $1.07B | $4.17B | $1.99B | $2.73B |
| Net Income | $7.57B | $7.58B | $3.13B | $7.03B |
| Net Income Ratio | $0.04 | $0.04 | $0.02 | $0.04 |
| EPS | $120.33 | $119.98 | $49.57 | $110.36 |
| Diluted EPS | $119.94 | $120.35 | $49.57 | $110.04 |
| Weighted Avg Shares Outstanding | $63.14M | $63.13M | $63.12M | $63.73M |
| Weighted Avg Shares Outstanding (Diluted) | $63.15M | $62.93M | $63.12M | $63.91M |
Over the past four quarters, Kaneka Corporation demonstrated steady revenue growth, increasing from $198.38B in Q1 2025 to $204.15B in Q4 2025. Operating income reached $9.90B in Q4 2025, maintaining a consistent 5% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $14.52B, reflecting operational efficiency. Net income dropped to $7.57B, with EPS at $120.33. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan